Replimune, Inc. will lay off 63 employees from its Woburn facility this month. The company has filed a Worker Adjustment and Retraining Notification (WARN) notice, indicating plans for workforce reduction.
Replimune, Inc. Announces Layoffs in Woburn
Replimune, Inc. will lay off employees, according to the WARN notice filed on April 13, 2026. The notice indicates a significant impact on the workforce; however, the affected job positions have not been disclosed in detail.
The layoffs are expected to take effect from April 13 through April 24, 2026, at the Woburn, Massachusetts, facility. The layoffs follow a setback involving the company’s cancer treatment candidate RP1.
On April 10, Replimune announced that the FDA issued a Complete Response Letter for its Biologics License Application seeking approval of RP1 in combination with nivolumab for advanced melanoma…